Announcements Trials

Browse Landscape

Phase

Status

Unknown 3 Terminated 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 13 Esophageal Squamous Cell Carcinoma 7 Rectal Neoplasms 4 Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Stomach Neoplasms 3 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Ovarian Neoplasms 2 Nasopharyngeal Carcinoma 2 Lung Neoplasms 2 Head and Neck Neoplasms 2 HER2-positive Breast Cancer 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Hepatocellular 2 Turcot syndrome 1 Testicular Neoplasms 1 Squamous Cell Carcinoma of External Auditory Canal 1 Seminoma 1 Recurrence 1 Pathologic Complete Response 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Neoplasms 1 Pancreatic Ductal Adenocarcinoma (PDAC) 1 Neoplastic Cells, Circulating 1 Neoplasm Metastasis 1 Neoadjuvant Therapy 1

Interventions

Dexamethasone 87 daratumumab 49 Lenalidomide 49 pomalidomide 33 Bortezomib 32 Cyclophosphamide 31 carfilzomib 25 Calcium Dobesilate 21 talquetamab 19 fludarabine 18 isatuximab 16 iberdomide 16 Magnetic Resonance Spectroscopy 16 Specimen Handling 15 Biopsy 14 selinexor 12 Melphalan 11 belantamab mafodotin 10 dexamethasone acetate 9 dexamethasone 21-phosphate 8 elotuzumab 7 auricularum 7 venetoclax 6 tocilizumab 5 fludarabine phosphate 5 X-Rays 5 Blood Specimen Collection 5 ruxolitinib 4 Methylprednisolone 4 Injections 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Multiple Myeloma × Neoadjuvant Therapy × Clear all

NCT07149857 2026-06-05

CARTITUDE-10

Janssen Research & Development, LLC

Phase 2 Recruiting

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡